Home › Rectal Cancer › Washington
Rectal Cancer clinical trials in Washington
9 studies for Rectal Cancer are looking for participants at sites in Washington.
Cities in Washington
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07283939Family Communications After Genetic Testing
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- and 17 more
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Fred Hutchinson Cancer Center ( Site 0076), Seattle
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06997497Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer
- Fred Hutch, Seattle
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05081024Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Valley Medical Center, Renton
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima
Recruiting
Ages 45 to 70 · All sexes · Updated Sep 2, 2026 · NCT05080673Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- FHCC Overlake, Bellevue
- FHCC at EvergreenHealth, Kirkland
- Virginia Mason Medical Center, Seattle
- and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT06205485A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Fred Hutchinson Cancer Center, Seattle
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06051695SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Seattle
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Fred Hutch Cancer Center, Seattle
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT06682793From ClinicalTrials.gov, data retrieved Oct 4, 2026. Each study sets its own eligibility; the study team decides who can join.